Curasight Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR). | Microvascular Therapeutics Microvascular Therapeutics (MVT) is a biotechnology company engaged in the development of an ultrasound contrast agent, MVT-100. | |
Founding Date | Founding Date 2013 | Founding Date 2016 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations København, DK HQ | Locations Tucson, US HQ |
Employees | Employees 7 | Employees 1220% increase |
Microvascular Therapeutics (MVT) is a biotechnology company engaged in the development of an ultrasound contrast agent, MVT-100.
View company